West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
239.26
0.00 (0.00%)
Aug 1, 2025, 4:00 PM - Market closed
HashiCorp Stock Forecast
Stock Price Forecast
The 6 analysts that cover HashiCorp stock have a consensus rating of "Buy" and an average price target of $332.5, which forecasts a 38.97% increase in the stock price over the next year. The lowest target is $245 and the highest is $400.
Price Target: $332.50 (+38.97%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for HashiCorp stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 6 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $285 → $320 | Strong Buy | Maintains | $285 → $320 | +33.75% | Jul 25, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $275 → $350 | Buy | Maintains | $275 → $350 | +46.28% | Jul 25, 2025 |
| Barclays | Barclays | Hold Initiates $245 | Hold | Initiates | $245 | +2.40% | Jun 24, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $275 | Buy | Initiates | $275 | +14.94% | Mar 18, 2025 |
| Keybanc | Keybanc | Buy Maintains $470 → $325 | Buy | Maintains | $470 → $325 | +35.84% | Feb 14, 2025 |
Financial Forecast
Revenue This Year
3.06B
from 2.89B
Increased by 5.70%
Revenue Next Year
3.24B
from 3.06B
Increased by 6.05%
EPS This Year
6.34
from 6.69
Decreased by -5.26%
EPS Next Year
7.18
from 6.34
Increased by 13.21%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.2B | 3.4B | 3.7B | ||
| Avg | 3.1B | 3.2B | 3.5B | ||
| Low | 2.9B | 3.0B | 3.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 11.1% | 12.7% | 14.0% | ||
| Avg | 5.7% | 6.0% | 6.5% | ||
| Low | 0.2% | -1.0% | 0.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.67 | 7.77 | 9.83 | ||
| Avg | 6.34 | 7.18 | 8.35 | ||
| Low | 6.10 | 6.62 | 7.26 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.3% | 22.6% | 37.0% | ||
| Avg | -5.3% | 13.2% | 16.4% | ||
| Low | -8.9% | 4.5% | 1.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.